Articles

Anti-diarrhoeal tablets that cause diarrhoea
Are Protein Pump Inhibitors safe in the long term?
Belching – A blessing or curse?
Colonic hydrotherapy: The Toxic Tide
Colonoscopy and colon cancer - Screening
Chronic Constipation - A Physiological Approach
Cyclical Vomiting: The missed diagnosis
Dan Brown, The Lost Symbol and Gastroenterology
Deteriorating Severe Ulcerative Colitis?
Diarrhoea is never caused by irritable bowel syndrome
Extraordinarly unhelpful investigations
Frozen Fritz – The Mythbuster
Gastrointestinal Symptoms and Exercise
Going where no-one has been before
Guidelines in IBD: A conspiracy?
Heartburn: A review
Imaging the small bowel
Irritable Bowel Syndrome: Back to Basics
Is a test too far a step too far?
Is it safe to stop aspirin after a bleed?
Leeches and Probiotics
Low dose aspirin and gastrointestinal bleeding
Obesity: A Modern Plague: Other Therapy
Obesity: A Modern Plague: Medical Therapy
Occult Blood Testing - is faecal occult testing passe?
Oesophageal Cancer incidence is rising
Osmotic laxatives: Are they safe?
Preventing colon cancer
Probiotics - Are they really helpful?
Reduced risk of colon cancer in ulcerative colitis
Severe retrosternal chest pain
Side effects and dangers associated with the treatment of Crohn's Disease and Ulcerative Colitis
The causes of nausea, vomiting and rumination
The Dangers of Eating Away From Home
The DNA Diet
The human diet - lessons from nature
The new step down therapy for IBD - Update
The pathophysiology of the irritable bowel syndrome
There is more to heartburn than acid
We are behind the curve in treating Crohn's Disease
Why persecute the Helicobacter pylori?

Colonoscopy and colon cancer - Screening Colonoscopy

Updated: 22 May 2007

Colonoscopy is generally accepted by the public, the profession and the funders to be the optimum method to screen patients for adenomas, enable their removal and therefore reduce the incidence of colorectal cancer. Even where occult blood testing is recommended colonoscopy remains the final verification of polyp/no-polyp. This rosy picture may not be entirely true.

The main problem area is the proximal colon as opposed to the recto-sigmoid and left colon. Here the Norwegian 1999 Telemark Polyp Study has shown that flexible sigmoidoscopy can reduce the incidence of colorectal cancer by 80%. This may well be too optimistic as the mortality rate was not changed and other studies from Norway have not yet confirmed this benefit.

Full colonoscopy, the preferred modality for colon cancer prevention was shown in the American 2007 National Polyp Study to lead to a reported 80% reduction in the incidence of colorectal cancer in patients who had undergone colonoscopy and polypectomy. Other studies supported these results. The 80% reduction has become the Holy Grail in colorectal cancer protection and hence the international recommendation of screening colonoscopy as part of any disease prevention program.

Other studies have not confirmed a 80% benefit and some have shown no benefit at all.

The reasons for this wide variation in outcome in colorectal cancer prevention studies has been debated and analyzed. Some of the problem is simply related to differences in study design. Entry and exit criteria, length of follow up and number of colonoscopies performed varies widely. A further observation is that cancers found in the first 3 years of follow up may well represent missed lesions at the primary / entry examination. That these possibly missed cancers tend to be proximal suggests that colonoscopic technique may be a central factor in colorectal cancer prevention. The risk of missed proximal colonic cancers is a theme that keeps recurring in the colorectal cancer prevention literature.

From the above it is reasonable to conclude that colonoscopic screening and polypectomy will prevent colorectal cancers. The problem is in the success of the procedure. There are two main areas of potential problems one is the patient preparation and the other is the expertise of the colonoscopist.

Taking preparation for colonoscopy on the day before the procedure has been shown to be inferior to that taken on the day of the procedure. The right colon is the main area to be obscured by poor preparation. The split method of some preparation on the day before and some on the day of, may be a reasonable alternative. The inferiority of the day before preparation is particularly important in the detection of right sided lesions which, as was indicated above, is the main problem area.

The passage of the colonoscope through to the caecum needs to be assured at all colonoscopies. It is recommended that photographic evidence be collected to confirm visualization of the caecal pole. Without this the examination cannot be assumed to be complete.

There is an inverse correlation between the polyp detection rate and the time taken to withdraw the colonoscope. While speed of execution is a peculiarly male measure of expertise it is alsoinappropriate in this context.

A third factor in the success of colonoscopy in colorectal cancer prevention is the data given to the patient. The patient needs to be informed on the adequacy of the examination. If the quality of preparation is sub-optimal and/or the full colon not visualised the patient needs to know. The next examination date taking this into account needs to be discussed clearly with the patient.

Finally the current recommendations for screening colonoscopy are:

  1. Everyone, without a history of colorectal cancer in parent or sibling, should have a colonoscopy at 50 years of age and another at 60 years of age.
  2. Those who do have the family history of colorectal cancer need a colonoscopy either 10 years before the family member’s diagnosis or at the age of 50 years if the family member was over 60 years old at diagnosis. This is then repeated at 55 and 60 years of age.

It is a strange, almost Biblical fact, that many patients with a family history are given too many colonoscopies while those without have none.